EUROPE MARKETS: Aveva Sinks; Novo Nordisk Climbs: Europe's Big Stock Movers
UPDATE: Aveva sinks; Novo Nordisk climbs: Europe's big stock movers
ADR Shares End Lower; Novo Nordisk Shares Trade Actively
UPDATE: Roche climbs on deal; banks higher: Europe's stock moves
Roche climbs on deal, banks higher: Europe movers
Focus remains on hemophilia competition, but Baxter's comprehensive product portfolios are unmatched.
Novel products will allow drug firms to achieve price premiums on diabetes drugs in the U.S. and at least retain level pricing internationally.
The diversified health-care firm remains remarkably profitable in tough industries.
Morningstar StockInvestor editor Matt Coffina explains why he recently purchased Novo Nordisk for StockInvestor's real-money Hare portfolio.
Morningstar StockInvestor editor Matt Coffina highlights three of the highest-quality companies we cover.